Articles On LBT Innovations (ASX:LBT)

Benchmark ASX index closes short by -0.04% Materials sector tries but cannot offset everyone else  Small caps led by HAL, DTC   The ASX200 Index has closed slightly lower after jumping early (+0.3%) out the gates on Wednesday morning. The...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

The Week That Was The world looks very different this week after the addition of what Barclays economic team calls ‘a complex cocktail of geopolitical risk, mixed macro data, a nervous oil market,’ and a US Fed finding nice things to say ab...

Benchmark ASX index closes -0.6% lower, but gains for the week ASX Sectors led by Utilities which jumped +5.0% since Monday Small caps led by HOR, FTZ, SWF   The ASX200 has closed lower on Friday, ending the session -0.6% lower, but ahe...

Oil prices fell as US crude stockpiles increased significantly by 10.2 million barrels, the largest rise since February, and demand for gasoline remained low, pushing gasoline futures to their lowest level since December 2022. Despite these...

  LBT Innovations (ASX:LBT) announced a $4.5m partially underwritten renounceable Entitlement Offer on a 4 for 1 basis. In response, LBT Chair, Ms Rebecca Wilson said, “Pleasingly we have secured underwriting commitments, including particip...

13 Oct 2023 - A snapshot of the stocks on the move, featuring LBT Innovations (ASX:LBT), Selfwealth (ASX:SWF) and Lucapa Diamond Co (ASX:LOM).

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Benchmark slides throughout the day after a shocker on Wall Street last night. Utilities did best but still ended up losing, down 0.3% for the day. Paincheck a ray of sunshine this afternoon, up 33% today despite an early speeding ticket....

Stockhead’s Top 10 at shortly-before-11-ish, published after I’ve had a chance to look over the numbers from the handful of short, fleeting minutes that the market’s been open, while quietly having a life-altering blast of existential panic...

The ASX 200 benchmark falls 0.6% as we brace for news from The Fed Sector losses led by Resources, while Consumers make gains Small caps led by Alderan, and BNPL Sezzle returns   Local markets made it a hat trick of losses, with the re...

The ASX 200 benchmark falls 0.5% as central bank boogeymen spook investors Energy pretty much on its own out front of the rest of the sectors Small caps led by lithium and new metal minnows with some sturdy new finds   Local markets hav...

Stockhead’s Top 10 at shortly-before-11-ish, published once our panel of the world’s best chocolatiers have sampled the wares, and deemed them worthy to be displayed in the fanciest windows of the fanciest stores, in the fanciest cities of...

Stockhead’s Top 10 at shortly-before-11-ish, published earlier than normal today, because of an uncharacteristic burst of optimistic energy, which may or may not be related to a change in medication. I’ll ask all the lizards seeping out of...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

ASX200 ends choppy day 0.2% higher Miners and med stocks offset banks and Energy  Small caps led by NickelSearch, Odin   All shook up, but home alive – Aussie shares somehow brought home the bacon on Tuesday, with both the All Ords and...

ASX 200 closes strongly on China data and iron ore futures after weak start Banks, Miners and Staples offset losses for Healthcare and IT Sectors Small caps led by CNW, OMX   Australian shares failed to launch before lunch on Monday, bu...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

The ASX 200 put on a much better show today, with a +0.46% gain at closing time Sectors wise, Materials turned yesterday’s frown upside down Notable performers today: Pilbara Minerals; DXN; Si6 Metals; Strickland Metals   It’s been a much...

The ASX 200 closed -0.10% in the red today, after feeling flat all day Sectors wise, Energy stocks carried the torch with enthusiasm, while Materials wasn’t let anywhere near said torch Notable performers today: pharma stock Telix (ASX:TLX...

ASX snaps a 4-day run of bruising luck with a welcome 1.5% gain Techies did a lot of the heavy lifting, while the Goldies put on a +3.54% show The day’s clear winner was Mobilicom, up 150% at day’s end on juicy defence news   Local market...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

ShareCafeLBT Innovations (ASX:LBT) – Webinar Presentation Brent Barnes – CEO and Managing Director – LBT Innovations (ASX:LBT) is a groundbreaking designer of advanced technology solutions for the medical industry. We specialise in bringin...

S&P/ASX 200 closes flat up just 0.07%, while the emerging companies index falls 0.48% Cellnet Group up 44% after a takeover bid by German private company Wentronic Holding GmbH Podium Minerals completes $2 million cap raise to advance...

Companies with exposure to Artificial Intelligence (AI), quantum technology, green energy, childcare and aged care are set to be bolstered by the delivery of Australia’s Federal Budget last evening. But companies focussed on offshore gas...

Australian medical technology company LBT Innovations (ASX:LBT) has announced that its chair, Joanne Moss, will retire from its board in the coming months.

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

ShareCafeASX closes 0.07% higher despite worrying food inflation data by Peter Milios   Reports from UBS show that food prices at Australia’s largest supermarket chains, Coles and Woolworths, jumped by 9.2 per cent in the December quarter,...

ShareCafeASX shakes off mornings gains: Aus shares down 0.15% at noon by Peter Milios   The ASX hit a fresh nine-month high this morning, after earnings from US tech companies helped lead US markets to big gains. However, since then, the AS...

ShareCafeWebinar Recap – AVE, LBT & SPX Catch up on the full webinar with presentations from Avecho (ASX: AVE), LBT Innovations (ASX: LBT) & Spenda (ASX: SPX) Webinar Recap – AVE, LBT & SPXCompany News

ShareCafeLBT Innovations (ASX: LBT) – Webinar Presentation Brent Barnes – CEO & MD – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. LBT Innovations (ASX: LBT) – Webinar Presentat...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

ShareCafeASX hits fourth consecutive gain: Aus shares close 0.59% higher by Peter Milios   Healthcare and Information Technology were the only sectors lagging in today’s session, whilst Energy and Real Estate led the day. In company news, t...

LBT Innovations (LBT) pens a deal with AstraZeneca to undertake full product development of its APAS Pharma artificial intelligence software The APAS Pharma analysis module will be developed to identify microbial growth on settle plates...

ShareCafeOvernight signs that US inflation is easing: Aus shares 1% higher at noon by Peter Milios   At noon, all sectors across the ASX are higher, after the release of the December jobs report data, as well as an economic activity survey....

ShareCafeStocks of the Hour: LBT, ESS, SBR                    LBT Innovations (ASX:LBT) has been engaged by AstraZeneca to undertake a full product development project for LBT’s new APAS Pharma analysis module, which will be used on t...

LBT Innovati0ns engaged by global pharma company, AstraZeneca Volpara nabs $7m plus contracts Imugene receives ethics approval for Vaxinia   LBT to partner with AstraZeneca LBT Innovations (ASX:LBT) surged 22%% this morning after announci...

09 Jan 2023 - A snapshot of the stocks on the move, featuring LBT Innovations, Essential Metals and Sabre Resources.

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Australian medical technology company LBT Innovations (ASX: LBT) will partner with global biopharmaceutical firm AstraZeneca for the full product development of its AP...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX takes a pre-Christmas bath, dragged down by InfoTech and Discretionary Asian markets fall lower today as Japan widens yield target range PolarX is still ruling the playground after one of the big kids said it was cool With apologies t...

20 Dec 2022 - A snapshot of the stocks on the move featuring Avecho Biotechnology (ASX:AVE), LBT Innovations (ASX:LBT) and Meteoric Resources (ASX:MEI).

Australian medical technology company LBT Innovations (ASX:LBT) has announced the appointment of Thermo Fisher Scientific as the exclusive distributor for the APAS Independence in Europe.